Trial intelligence / Profile preview

SMX-TMP vs Aerosolized Pentamidine for Secondary Prophylaxis of PCP in AIDS Patients on AZT

NCT00000727Phase 3Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of trimethoprim + sulfamethoxazole, pentamidine in Pneumocystis pneumonia (PCP), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.

02

Drugs

trimethoprim + sulfamethoxazolepentamidine
03

Conditions

Pneumocystis pneumonia (PCP)

Beyond the preview

Go deeper on NCT00000727.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000727.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call